Literature DB >> 9809372

Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque.

C S Raine1, B Bonetti, B Cannella.   

Abstract

The molecules that comprise the tumor necrosis factor ligand and receptor (TNF-L and TNF-R) families play important roles in tissue homeostasis and in multiple sclerosis (MS). For example, levels of the TNF ligand (TNF alpha; cachectin) correlate with disease progression and lymphotoxin (LT, TNF beta) has been localized in MS lesions. Members of the TNF-R family are typical signal sensors which upon binding with ligand aggregate and recruit signal transducers. To date, no TNF-R molecules have been reported in MS although TNF-RI and RII have been localized to oligodendrocytes in culture. In the present study, the expression of TNF, LT alpha (the soluble form of LT), LT beta (the beta chain of LT alpha beta, the membrane-bound form of LT), TNF-RI, TNF-RII, LT beta-R, FasL, and Fas receptor in MS lesions has been examined by immunohistochemistry for protein and by RT-PCR for mRNA. In addition, the TUNEL technique for DNA fragmentation was applied to detect apoptosis. The results have shown that contrarily to predictions, oligodendrocytes around active MS lesions frequently expressed TNF-R molecules belonging to the apoptotic cascade. However, these cells did not undergo apoptosis, as judged by TUNEL. On the other hand, lymphocytes (and a few microglial cells) in the same tissue displayed apoptosis. Microglial cells were the major effector cells in the CNS and expressed TNF, LT alpha and FasL. LT beta expression was seen on astrocytes and oligodendrocytes, and LT beta-R on astrocytes. We conclude that TNF-L and TNF-R molecules are extensively expressed in MS, that their expression occurs at high levels but is not specific for MS, and that oligodendrocytes are depleted by a cytolytic mechanism, not by apoptosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9809372

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  22 in total

Review 1.  The role of TNFalpha and lymphotoxin in demyelinating disease.

Authors:  C Lock; J Oksenberg; L Steinman
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  Astrocytes promote TNF-mediated toxicity to oligodendrocyte precursors.

Authors:  Sunja Kim; Andrew J Steelman; Hisami Koito; Jianrong Li
Journal:  J Neurochem       Date:  2010-12-02       Impact factor: 5.372

3.  Genetic deletion of TNF receptor suppresses excitatory synaptic transmission via reducing AMPA receptor synaptic localization in cortical neurons.

Authors:  Ping He; Qiang Liu; Jie Wu; Yong Shen
Journal:  FASEB J       Date:  2011-10-07       Impact factor: 5.191

Review 4.  Glial development: the crossroads of regeneration and repair in the CNS.

Authors:  Vittorio Gallo; Benjamin Deneen
Journal:  Neuron       Date:  2014-07-16       Impact factor: 17.173

5.  SSeCKS promotes tumor necrosis factor-alpha autocrine via activating p38 and JNK pathways in Schwann cells.

Authors:  Zhengming Zhou; Tao Tao; Yuhong Ji; Huiguang Yang; Youhua Wang; Chun Cheng; Aiguo Shen; Xiang Lu
Journal:  Cell Mol Neurobiol       Date:  2010-01-29       Impact factor: 5.046

6.  Analysis of gene expression in MOG-induced experimental autoimmune encephalomyelitis after treatment with a novel brain-penetrating antioxidant.

Authors:  Yossi Gilgun-Sherki; Yael Barhum; Daphne Atlas; Eldad Melamed; Daniel Offen
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

7.  Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination.

Authors:  Roberta Brambilla; Jessica Jopek Ashbaugh; Roberta Magliozzi; Anna Dellarole; Shaffiat Karmally; David E Szymkowski; John R Bethea
Journal:  Brain       Date:  2011-09       Impact factor: 13.501

8.  TNF-alpha as an autocrine mediator and its role in the activation of Schwann cells.

Authors:  Yongwei Qin; Chun Cheng; Haibo Wang; Xiaoyi Shao; Yongjing Gao; Aiguo Shen
Journal:  Neurochem Res       Date:  2008-01-17       Impact factor: 3.996

Review 9.  Lame ducks or fierce creatures? The role of oligodendrocytes in multiple sclerosis.

Authors:  T Zeis; N Schaeren-Wiemers
Journal:  J Mol Neurosci       Date:  2008-02-16       Impact factor: 3.444

Review 10.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.